paediatrics Brussels 17

AREN0532/AREN0533

1134

35 (3.1%) LOH 1p and 16q Stage I/II

52 (4.6%) LOH 1p and 16q Stage III/IV

1047 No LOH 1p and 16q Stage I/II/III/IV

EE4A for Stage I/II DD4A for Stage III/IV with RT*

DD4A without RT

Regimen M with RT

Dix DB et al. J Clin Oncol 33, 2015 (suppl; abstr 10009)